| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | -0.043 | 0.3 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.3 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.068 | 0.3 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |